194 related articles for article (PubMed ID: 28758908)
1. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
Jaworska D; Szliszka E
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
[TBL] [Abstract][Full Text] [Related]
2. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
Szliszka E; Helewski KJ; Mizgala E; Krol W
Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
[TBL] [Abstract][Full Text] [Related]
3. Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress.
Grayson KA; Hope JM; Wang W; Reinhart-King CA; King MR
Mol Cancer Ther; 2021 May; 20(5):833-845. PubMed ID: 33632873
[TBL] [Abstract][Full Text] [Related]
4. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
Acikgoz E; Guven U; Duzagac F; Uslu R; Kara M; Soner BC; Oktem G
PLoS One; 2015; 10(10):e0141090. PubMed ID: 26485709
[TBL] [Abstract][Full Text] [Related]
5. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
[TBL] [Abstract][Full Text] [Related]
6. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
7. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
[TBL] [Abstract][Full Text] [Related]
8. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
Zhang X; Jin TG; Yang H; DeWolf WC; Khosravi-Far R; Olumi AF
Cancer Res; 2004 Oct; 64(19):7086-91. PubMed ID: 15466204
[TBL] [Abstract][Full Text] [Related]
9. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.
Shimada O; Wu X; Jin X; Nouh MA; Fiscella M; Albert V; Matsuda T; Kakehi Y
Urology; 2007 Feb; 69(2):395-401. PubMed ID: 17320696
[TBL] [Abstract][Full Text] [Related]
10. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis.
Griffith TS; Kemp TJ
Cancer Chemother Pharmacol; 2003 Sep; 52(3):175-84. PubMed ID: 12811515
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
El-Zawahry A; McKillop J; Voelkel-Johnson C
BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938
[TBL] [Abstract][Full Text] [Related]
12. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
Shankar S; Chen X; Srivastava RK
Prostate; 2005 Feb; 62(2):165-86. PubMed ID: 15389801
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
Deeb DD; Jiang H; Gao X; Divine G; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2005; 5(2):81-91. PubMed ID: 16471035
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.
Labsch S; Liu L; Bauer N; Zhang Y; Aleksandrowicz E; Gladkich J; Schönsiegel F; Herr I
Int J Oncol; 2014 May; 44(5):1470-80. PubMed ID: 24626333
[TBL] [Abstract][Full Text] [Related]
15. The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Czuba ZP; Mertas A; Paradysz A; Krol W
Urol Oncol; 2013 Apr; 31(3):331-42. PubMed ID: 21803611
[TBL] [Abstract][Full Text] [Related]
16. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
[TBL] [Abstract][Full Text] [Related]
18. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
[TBL] [Abstract][Full Text] [Related]
19. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.
Erdogan S; Serttas R; Turkekul K; Dibirdik I
Mol Biol Rep; 2022 Jun; 49(6):4873-4884. PubMed ID: 35705771
[TBL] [Abstract][Full Text] [Related]
20. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
